Telix Pharmaceuticals Limited · 1 month ago
Global Regulatory Affairs - CMC Talent Community
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with a mission to deliver precision medicine through targeted radiation. The Global Regulatory CMC team is responsible for authoring CMC specific regulatory dossiers and ensuring compliance with evolving regulatory requirements for the development and commercialization of radiopharmaceutical and biopharmaceutical products.
Biotechnology
Responsibilities
Plan, prepare/revise eCTD Module 2.3 & Module 3 documents for INDs, IMPDQs, NDAs, BLAs, MAAs, CTAs, post-approval supplements and variation submissions, ensuring accuracy and completeness
Ensure Module 3 documentation is planned, tracked, clearly written, with the use of regulatory domain systems (Veeva) and processes
Stay current and interpret evolving CMC regulatory requirements and guidelines such as ICH, US FDA CFRs, EMA Directives and Annexes. Ensure CMC documentation and data are compliant with regulations
Collaborate with internal stakeholders, including Quality Assurance, CMC/Manufacturing, and preclinical teams for planning and authoring of CMC regulatory scope and content
Provide regulatory assessments for manufacturing changes, including site transfers, scale-up activities, and process changes. Conduct comparability assessments and develop post-approval supplements as needed
Qualification
Required
Undergraduate degree required
Experience with a strong focus on CMC in the radiopharmaceutical or biopharmaceutical industry
Solid understanding of global regulatory requirements and guidelines for CMC, including ICH guidelines and FDA, EMA, and other health authority regulations
Excellent technical writing and verbal communication skills, with the ability to effectively communicate complex regulatory issues to internal and external stakeholders
Good analytical and problem-solving skills, with the ability to assess and mitigate regulatory risks
Ability to work collaboratively and build effective relationships across functions and geographies
Skilled at summarizing pharmaceutical manufacturing and method development reports, data into appropriate sub-sections of Module 3
Preferred
Advanced degree (M.Sc., Ph.D.) with a focus in Biological Sciences, Engineering or a related field
Benefits
Competitive salaries
Annual performance-based bonuses
An equity-based incentive program
Generous vacation
Paid wellness days
Support for learning and development
Company
Telix Pharmaceuticals Limited
Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals.
Funding
Current Stage
Public CompanyTotal Funding
$493.27MKey Investors
Australian Government
2024-07-23Post Ipo Debt· $429.77M
2022-04-04Grant· $23M
2020-03-16Grant· $0.5M
Recent News
2026-01-16
2026-01-13
Company data provided by crunchbase